Immatics (IMTX) EBIT Margin Growth (3y) (2022 - 2025)
Immatics (IMTX) EBIT Margin Growth (3y) (2022 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Immatics |
14.67 Bn |
14.67 Bn |
- |
-19,688.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
-19,688.00 |
| Sep 30, 2025 |
-90,768.00 |
| Jun 30, 2025 |
-102,477.00 |
| Mar 31, 2025 |
-25,692.00 |
| Dec 31, 2024 |
10,485.00 |
| Sep 30, 2024 |
35,944.00 |
| Jun 30, 2024 |
30,924.00 |
| Mar 31, 2024 |
27,751.00 |
| Dec 31, 2023 |
3,798.00 |
| Sep 30, 2023 |
-32,256.00 |
| Jun 30, 2023 |
22,017.00 |
| Mar 31, 2023 |
-10,956.00 |
| Dec 31, 2022 |
28,027.00 |
| Sep 30, 2022 |
782.00 |
| Jun 30, 2022 |
2,098.00 |
